---
schema_version: "secwatch.filing_event.v1"
accession: "0000885725-21-000032"
form_type: "8-K/A"
ticker: "BSX"
cik: "0000885725"
company_name: "BOSTON SCIENTIFIC CORP"
filed_at: "2021-08-02T23:59:59+00:00"
generated_at: "2026-06-30T00:11:16.191087+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# David S. Wichmann appointed to Audit and Risk Committees of Boston Scientific Board

## Summary
- Appointed to Board of Directors on June 23, 2021; committee assignments set on July 28, 2021.
- Will serve on Audit Committee and Risk Committee effective July 28, 2021.
- No other changes to Board composition or leadership.

## SEC filing metadata
- accession: 0000885725-21-000032
- form_type: 8-K/A
- ticker: BSX
- cik: 0000885725
- company_name: BOSTON SCIENTIFIC CORP
- filed_at: 2021-08-02T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/885725/000088572521000032/0000885725-21-000032-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/885725/000088572521000032/bsx-20210623.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000885725-21-000032
- JSON: https://secwatch.observer/filing/0000885725-21-000032.json
- Plain text: https://secwatch.observer/filing/0000885725-21-000032.txt

## Key facts
- Executive change
  David S. Wichmann was appointed as Director at BOSTON SCIENTIFIC CORP.
  - Action: appointed
  - Role: Director
  source text: On June 24, 2021, Boston Scientific Corporation (the “Company”) filed a Current Report on Form 8-K announcing the appointment of David S. Wichmann to the Company’s Board of Directors (the “Board”) on June 23, 2021.
  evidence_url: https://www.sec.gov/Archives/edgar/data/885725/000088572521000032/0000885725-21-000032-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.